Book
Management of Sepsis and Septic Shock 2026
- REFERENCES
1. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic shock 2026. Critical Care Medicine April 2026; 54 (4): 715-812
2. Singer M, Deutschman CS, Seymour CW, et al: The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315:801–810
3. Arabi YM, Alsaawi A, Alzahrani M, et al; SCREEN Trial Group and the Saudi Critical Care Trials Group: Electronic sepsis screening among patients admitted to hospital wards: A stepped-wedge cluster randomized trial. JAMA 2025; 333:763–773
4. Freund Y, Cancella de Abreu M, Lebal S, et al: Effect of the 1-h bundle on mortality in patients with suspected sepsis in the emergency department: A stepped wedge cluster randomized clinical trial. Intensive Care Med 2024; 50:1086–1095
5. Damiani E, Donati A, Serafini G, et al: Effect of performance improvement programs on compliance with sepsis bundles and mortality: A systematic review and meta-analysis of observational studies. PLoS One 2015; 10:e0125827
6. Tarabichi Y, Cheng A, Bar-Shain D, et al: Improving timeliness of antibiotic administration using a provider and pharmacist facing sepsis early warning system in the emergency department setting: A randomized controlled quality improvement initiative. Crit Care Med 2022; 50:418–427
7. CDC: Hospital Sepsis Program Core Elements. 2023. Available at: https://www.cdc.gov/sepsis/media/pdfs/sepsis- core-elements-H.pdf Accessed August 14, 2025
8. Guirgis FW, Jones L, Esma R, et al: Managing sepsis: Electronic recognition, rapid response teams, and standardized care save lives. J Crit Care 2017; 40:296–302
9. Patocka C, Turner J, Xue X, et al: Evaluation of an emergency department triage screening tool for suspected severe sepsis and septic shock. J Healthc Qual 2014; 36:52–61; quiz 59
10. Williams G, Alberto L, Taha M, et al: The challenges of compliance with sepsis management protocols in low and low-middle income countries - A cross-sectional study. Intensive Crit Care Nurs 2025; 90:104032
11. Piedmont S, Goldhahn L, Swart E, et al: Sepsis incidence, suspicion, prediction and mortality in emergency medical services: A cohort study related to the current international sepsis guideline. Infection 2024; 52:1325–1335
12. Troncoso R Jr, Garfinkel EM, Hinson JS, et al: Do prehospital sepsis alerts decrease time to complete CMS sepsis measures? Am J Emerg Med 2023; 71:81–85
13. Hunter CL, Silvestri S, Stone A, et al: Prehospital sepsis alert notification decreases time to initiation of CMS sepsis core measures. Am J Emerg Med 2019; 37:114–117
14. Guerra WF, Mayfield TR, Meyers MS, et al: Early detection and treatment of patients with severe sepsis by prehospital personnel. J Emerg Med 2013; 44:1116–1125
15. Mixon M, Dietrich S, Floren M, et al: Time to antibiotic administration: Sepsis alerts called in emergency department versus in the field via emergency medical services. Am J Emerg Med 2021; 44:291–295
16. Adegbite BR, Edoa JR, Ndzebe Ndoumba WF, et al: A comparison of different scores for diagnosis and mortality prediction of adults with sepsis in Low-and-Middle-Income Countries: A systematic review and meta-analysis. E Clinical Medicine 2021; 42:101184
17. Chua WL, Rusli KDB, Aitken LM: Early warning scores for sepsis identification and prediction of in-hospital mortality in adults with sepsis: A systematic review and meta-analysis. J Clin Nurs 2024; 33:2005–2018
18. Elperin J, Van Perre K, Bryant NH: 1193: Sepsis: Is it time to leave sirs behind? A systematic review and meta-analysis of sepsis definitions. Crit Care Med 2023; 51:59
19. Qiu X, Lei Y, Zhou RX: SIRS, SOFA, qSOFA, and NEWS in the diagnosis of sepsis and prediction of adverse outcomes: A systematic review and meta-analysis. Expert Rev Anti Infect Ther 2023; 21:891–900
20. Crouser ED, Parrillo JE, Seymour CW, et al: Monocyte distribution width: A novel indicator of sepsis-2 and sepsis-3 in high- risk emergency department patients. Crit Care Med 2019; 47:1018–1025
21. Vashti A, Mullan PJ, Nitzberg M: Single-site sampling strategy versus multi-site sampling strategy in blood culture collection within the hospital setting: A systematic review. Am J Infect Control 2025; 53:1113–1120
22. S3-Leitlinie: Sepsis – Prävention, Diagnose, Therapie und Nachsorge – Update 2025. Available at: https://reg- ister.awmf.org/assets/guidelines/079-001l_S3_Sepsis-Praevention-Diagnose-Therapie-Nachsorge_2025-07.pdf Accessed August 12, 2025
23. Cheng MP, Stenstrom R, Paquette K, et al; FABLED Investigators: Blood culture results before and after anti- microbial administration in patients with severe manifestations of sepsis: A diagnostic study. Ann Intern Med 2019; 171:547–554
24. Evans L, Rhodes A, Alhazzani W, et al: Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock 2021. Intensive Care Med 2021; 47:1181–1247
25. Evans L, Rhodes A, Alhazzani W, et al: Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock 2021. Crit Care Med 2021; 49:e1063–e1143
26. Borthwick HA, Brunt LK, Mitchem KL, et al: Does lactate measurement performed on admission predict clinical outcome on the intensive care unit? A concise systematic review. Ann Clin Biochem 2012; 49:391–394
27. Liu G, An Y, Yi X, et al: Early lactate levels for prediction of mortality in patients with sepsis or septic shock: A meta-analysis. Int J Exp Med 2017; 10:37–47
28. Levy MM, Evans LE, Rhodes A: The surviving sepsis campaign bundle: 2018 update. Crit Care Med 2018; 46:997–1000
29. Shankar-Hari M, Phillips GS, Levy ML, et al; Sepsis Definitions Task Force: Developing a new definition and assessing new clinical criteria for septic shock: For the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315:775–787
30. Ljungström L, Pernestig AK, Jacobsson G, et al: Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein, and lactate in patients with suspected bacterial sepsis. PLoS One 2017; 12:e0181704
31. Morris E, McCartney D, Lasserson D, et al: Point-of-care lactate testing for sepsis at presentation to health care: A systematic review of patient outcomes. Br J Gen Pract 2017; 67:e859–e870
32. Rhodes A, Evans LE, Alhazzani W, et al: Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med 2017; 45:486–552
33. Shankar-Hari M, Phillips GS, Levy ML, et al; Sepsis Definitions Task Force: Developing a new definition and assessing new clinical criteria for septic shock: For the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315:775–787
34. Kuttab HI, Lykins JD, Hughes MD, et al: Evaluation and predictors of fluid resuscitation in patients with severe sepsis and septic shock. Crit Care Med 2019; 47:1582–1590
35. Corl KA, Levy MM, Holder AL, et al: Moderate IV fluid resuscitation is associated with decreased sepsis mortality. Crit Care Med 2024; 52:e557–e567
36. Peake SL, Delaney A, Bellomo R; ARISE Investigators: Goal- directed resuscitation in septic shock. N Engl J Med 2015; 372:190–191
37. Pro CI, et al.: A randomized trial of protocol-based care for early septic shock. N Engl J Med 2014; 370:1683–1693
38. Mouncey PR, Osborn TM, Power GS, et al; ProMISe Trial Investigators: Trial of early, goal-directed resuscitation for septic shock. N Engl J Med 2015; 372:1301–1311
39. Ward MA, Kuttab HI, Badgett RG: The effect of early fluid resuscitation on mortality in sepsis: A systematic review and meta-analysis. Crit Care Med 2025; 53:e1790–e1802
40. Taylor SP, Karvetski CH, Templin MA, et al: Initial fluid resus- citation following adjusted body weight dosing is associated with improved mortality in obese patients with suspected septic shock. J Crit Care 2018; 43:7–12
41. Mekontso Dessap A, AlShamsi F, Belletti A, et al; European Society of Intensive Care Medicine: European Society of Intensive Care Medicine (ESICM) 2025 clinical practice guideline on fluid therapy in adult critically ill patients: Part 2-the volume of resuscitation fluids. Intensive Care Med 2025; 51:461–477
42. Ahn C, Yu G, Shin TG, et al: Comparison of early and late norepinephrine administration in patients with septic shock: A systematic review and meta-analysis. Chest 2024; 166:1417–1430
43. Permpikul C, Tongyoo S, Viarasilpa T, et al: Early use of norepinephrine in septic shock resuscitation (CENSER). A randomized trial. Am J Respir Crit Care Med2019; 199:1097–1105
44. Shi R, Braïk R, Monnet X, et al: Early norepinephrine for patients with septic shock: An updated systematic review and meta-analysis with trial sequential analysis. Crit Care2025; 29:182
45. Li Y, Li H, Zhang D: Timing of norepinephrine initiation in patients with septic shock: A systematic review and meta-analysis. Crit Care2020; 24:488
46. Zhou HX, Yang C-F, Wang H-Y, et al: Should we initiate vasopressors earlier in patients with septic shock: A mini systemic review. World J Crit Care Med2023; 12:204–216
47. Elbouhy MA, Soliman M, Gaber A, et al: Early use of norepinephrine improves survival in septic shock: Earlier than early. Arch Med Res2019; 50:325–332
48. Bai X, Yu W, Ji W, et al: Early versus delayed administration of norepinephrine in patients with septic shock. Crit Care2014; 18:532
49. Colon Hidalgo D, Patel J, Masic D, et al: Delayed vasopressor initiation is associated with increased mortality in patients with septic shock. J Crit Care2020; 55:145–148
50. National Heart L, et al.: Early restrictive or liberal fluid management for sepsis-induced hypotension. The multicenter CLOVERS RCT. N Engl J Med2023; 388:499–510
51. Owen VS, Rosgen BK, Cherak SJ, et al: Adverse events associated with administration of vasopressor medications through a peripheral intravenous catheter: A systematic review and meta-analysis. Crit Care2021; 25:146
52. Tian DH, Smyth C, Keijzers G, et al: Safety of peripheral administration of vasopressor medications: A systematic review. Emerg Med Australas2020; 32:220–227
53. Ricard JD, Salomon L, Boyer A, et al: Central or peripheral catheters for initial venous access of ICU patients: A randomized controlled trial. Crit Care Med2013; 41:2108–2115
54. Stolz A, Efendy R, Apte Y, et al: Safety and efficacy of peripheral versus centrally administered vasopressor infusion: A single-center retrospective observational study. Aust Crit Care2022; 35:506–511
55. Delaney A, Finnis M, Bellomo R, et al: Initiation of vasopressor infusions via peripheral versus central access in patients with early septic shock: A retrospective cohort study. Emerg Med Australas2020; 32:210–219
56. Munroe ES, Heath ME, Eteer M, et al: Use and outcomes of peripheral vasopressors in early sepsis-induced hypotension across Michigan hospitals: A retrospective cohort study. Chest2024; 165:847–857
57. Munroe ES, Co IN, Douglas I, et al; NHLBI PETAL Network: Peripheral vasopressor use in early sepsis-induced hypotension. JAMA Netw Open2025; 8:e2529148
58. Asher E, Karameh H, Nassar H, et al; Jerusalem Platelets Thrombosis and Intervention in Cardiology (JUPITER-16) Study Group: Safety and outcomes of peripherally administered vasopressor infusion in patients admitted with shock to an intensive cardiac care unit-A single-center prospective study. J Clin Med2023; 12:5734
59. Groetzinger LM, Williams J, Svec S, et al: Peripherally infused norepinephrine to avoid central venous catheter placement in a medical intensive care unit: A pilot study. Ann Pharmacother2022; 56:773–781
60. Medlej K, Kazzi AA, El Hajj Chehade A, et al: Complications from administration of vasopressors through peripheral ve-nous catheters: An observational study. J Emerg Med2018; 54:47–53
61. Meng L, Wang Y, Zhang L, et al: Heterogeneity and variability in pressure autoregulation of organ blood flow: lessons learned over 100+ years. Crit Care Med2019; 47:436–448
62. Asfar P, Meziani F, Hamel J-F, et al; SEPSISPAM Investigators: High versus low blood-pressure target in patients with septic shock. N Engl J Med2014; 370:1583–1593
63. Hylands M, Moller MH, Asfar P, et al: A systematic review of vasopressor blood pressure targets in critically ill adults with hypotension. Can J Anaesth2017; 64:703–715
64. Lamontagne F, Richards-Belle A, Thomas K, et al; 65 trial investigators: Effect of reduced exposure to vasopressors on 90-day mortality in older critically ill patients with vasodilatory hypotension: A randomized clinical trial. JAMA2020; 323:938–949
65. Angriman F, Momenzade N, Adhikari NKJ, et al: Blood pressure targets for adults with vasodilatory shock - An individual patient data meta-analysis. NEJM Evid2025;4:EVIDoa 2400359
66. Endo A, Yamakawa K, Tagami T, et al; OPTPRESS trial investigators: Efficacy of targeting high mean arterial pressure for older patients with septic shock (OPTPRESS): A multicenter , pragmatic, open-label, randomized controlled trial. Intensive Care Med2025; 51:883–892
67. Cardoso LT, Grion CM, Matsuo T, et al: Impact of delayed admission to intensive care units on mortality of critically ill patients: A cohort study. Crit Care 2011; 15:R28
68. Groenland CNL, Termorshuizen F, Rietdijk WJR, et al: Emergency department to ICU time is associated with hospital mortality: A registry analysis of 14,788 patients from Six University Hospitals in The Netherlands. Crit Care Med 2019; 47:1564–1571
69. Chalfin DB, Trzeciak S, Likourezos A, et al; DELAY-ED study group: Impact of delayed transfer of critically ill patients from the emergency department to the intensive care unit. Crit Care Med 2007; 35:1477–1483
70. Harris S, Singer M, Sanderson C, et al: Impact on mortality of prompt admission to critical care for deteriorating ward patients: An instrumental variable analysis using critical care bed strain. Intensive Care Med 2018; 44:606–615
71. Kalil AC, Johnson DW, Lisco SJ, et al: Early goal-directed therapy for sepsis: A novel solution for discordant survival outcomes in clinical trials. Crit Care Med 2017; 45:607–614
72. Klompas M, Calandra T, Singer M: Antibiotics for sepsis-finding the equilibrium. JAMA2018; 320:1433–1434
73. Leung LY, Huang H-L, Hung KK, et al: Door-to-antibiotic time and mortality in patients with sepsis: Systematic review and meta-analysis. Eur J Intern Med2024; 129:48–61
74. Pak TR, Young J, McKenna CS, et al: Risk of misleading conclusions in observational studies of time-to-antibiotics and mortality in suspected sepsis. Clin Infect Dis2023; 77:1534–1543
75. Hechtman RK, Kipnis P, Cano J, et al: Heterogeneity of benefit from earlier time-to-antibiotics for sepsis. Am J Respir Crit Care Med2024; 209:852–860
76. Alam N, Oskam E, Stassen PM, et al; PHANTASi Trial Investigators and the ORCA (Onderzoeks Consortium Acute Geneeskunde) Research Consortium the Netherlands: Prehospital antibiotics in the ambulance for sepsis: A multicenter, open label, randomized trial. Lancet Respir Med2018; 6:40–50
77. Thwaites L, Nasa P, Abbenbroek B, et al: Management of adult sepsis in resource-limited settings: Global expert consensus statements using a Delphi method. Intensive Care Med 2025; 51:21–38
78. Lane D, Ichelson RI, Drennan IR, et al: Prehospital management and identification of sepsis by emergency medical serv- ices: A systematic review. Emerg Med J 2016; 33:408–413
79. Varney J, Motawea KR, Kandil OA, et al: Prehospital administration of broad-spectrum antibiotics for sepsis patients: A systematic review and meta-analysis. Health Sci Rep 2022; 5:e582
80. Poynter MJ, Farrugia A, Kelly E, et al: Prehospital administration of antibiotics in addition to usual care versus usual care alone for patients with suspected sepsis – a systematic review. Paramedicine 2023; 21:52–65
81. Peng F, Chang W, Xie JF, et al: Ineffectiveness of procalcitonin-guided antibiotic therapy in severely critically ill patients: A meta-analysis. Int J Infect Dis 2019; 85:158–166
82. Wacker C, Prkno A, Brunkhorst FM, et al: Procalcitonin as a diagnostic marker for sepsis: A systematic review and meta-analysis. Lancet Infect Dis 2013; 13:426–435
83. Jensen JU, Hein L, Lundgren B, et al; Procalcitonin And Survival Study (PASS) Group: Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: A randomized trial. Crit Care Med 2011; 39:2048–2058
84. Layios N, Lambermont B, Canivet JL, et al: Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients. Crit Care Med 2012; 40:2304–2309
85. Najafi A, Khodadadian A, Sanatkar M, et al: The comparison of procalcitonin guidance administer antibiotics with empiric antibiotic therapy in critically ill patients admitted in intensive care unit. Acta Med Iran 2015; 53:562–567
86. Metlay JP, Waterer GW, Long AC, et al: Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med 2019; 200:e45–e67
87. Huston JM, Barie PS, Dellinger EP, et al: Surgical infection society guidelines on management of intra-abdominal infection: 2024 update. Surg Infect (Larchmt) 2024; 25:419–435
88. Coccolini F, Sartelli M, Sawyer R, et al: Source control in emergency general surgery: WSES, GAIS, SIS-E, SIS-A guidelines. World J Emerg Surg 2023; 18:41
89. Paul M, Carrara E, Retamar P, et al: European society of clinical microbiology and infectious diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine). Clin Microbiol Infect 2022; 28:521–547
90. Carey GB, Holleck JL, Ein Alshaeba S, et al: Estimated mortality with early empirical MRSA coverage in hospitalized patients: Systematic review and meta-analysis. J Antimicrob Chemother 2023; 78:1150–1159
91. Cortegiani A, Russotto V, Maggiore A, et al: Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients. Cochrane Database Syst Rev 2016; 2016:CD004920
92. Timsit JF, Azoulay E, Schwebel C, et al; EMPIRICUS Trial Group: Empirical micafungin treatment and survival without invasive fungal infection in adults with ICU-acquired sepsis (EMPIRICUS). JAMA 2016; 316:1555–1564
93. Petersen MW, Perner A, Jonsson AB, et al: Empirical metronidazole for patients with severe bacterial infection: Systematic review with meta-analysis and trial sequential analysis. Acta Anaesthesiol Scand 2019; 63:802–813
94. Chanderraj R, Baker JM, Kay SG, et al: In critically ill patients, anti-anaerobic antibiotics increase risk of adverse clinical outcomes. Eur Respir J 2023; 61:2200910
95. Metlay JP, Waterer GW, Long AC, et al: Diagnosis and treatment of adults with community-acquired pneumonia. ATS/IDSA guideline. Am J Respir Crit Care Med 2019; 200:e45–e67
96. Mazuski JE, Tessier JM, May AK, et al: Surgical Infection Society revised guidelines on management of intra-abdominal infection. Surg Infect (Larchmt) 2017; 18:1–76
97. Kullberg RFJ, Haak BW, Chanderraj R, et al: Empirical antibiotic therapy for sepsis: Save the anaerobic microbiota. Lancet Respir Med 2025; 13:92–100
98. Anton-Vazquez V, Hine P, Krishna S, et al: Rapid versus standard antimicrobial susceptibility testing to guide treatment of bloodstream infection. Cochrane Database Syst Rev 2021; 5:CD013235
99. Caspar Y, Deves A, Richarme C, et al: Clinical impact and cost-consequence analysis of ePlex® blood culture identification panels for rapid diagnosis of bloodstream infections. Eur J Clin Microbiol Infect Dis 2024; 43:1193–1203
100. Timbrook TT, Morton JB, McConeghy KW, et al: The effect of molecular rapid diagnostic testing on clinical outcomes in bloodstream infections: Systematic review and meta-analysis. Clin Infect Dis 2017; 64:15–23
101. Mohd Hafiz AA, Staatz CE, Kirkpatrick CMJ, et al: Continuous infusion vs. bolus dosing: Implications for beta-lactam antibiotics. Minerva Anesthesiol 2012; 78:94–104
102. Abdul-Aziz MH, Lipman J, Akova M, et al; DALI Study Group: Is prolonged infusion of piperacillin/tazobactam and meropenem associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? (DALI cohort). J Antimicrob Chemother 2016; 71:196–207
103. Abdul-Aziz MH, Hammond NE, Brett SJ, et al: Prolonged vs intermittent infusions of beta-lactam antibiotics in adults with sepsis or septic shock: A systematic review and meta-analysis. JAMA 2024; 332:638–648
104. Dulhunty JM, Brett SJ, De Waele JJ, et al; BLING III Study Investigators: Continuous vs intermittent beta-lactam antibiotic infusions in critically ill patients with sepsis: The BLING III randomized clinical trial. JAMA 2024; 332:629–637
105. Roberts JA, Abdul-Aziz MH, Lipman J, et al: Individualized antibiotic dosing for patients who are critically ill: Challenges and potential solutions. Lancet Infect Dis 2014; 14:498–509
106. Veiga R, Paiva JA: Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients. Crit Care 2018; 22:233
107. Sanz-Codina M, Bozkir HO, Jorda A, et al: Individualized antimicrobial dose optimization: A systematic review and meta-analysis of randomized controlled trials. Clin Microbiol Infect 2023; 29:845–857
108. Abdul-Aziz MH, Alffenaar JC, Bassetti M, et al; ESICM Infection Section: Antimicrobial therapeutic drug monitoring in critically ill adult patients: A Position Paper. Intensive Care Med 2020; 46:1127–1153
109. Leone M, Bechis C, Baumstarck K, et al; AZUREA Network Investigators: De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: A multicenter non-blinded randomized noninferiority trial. Intensive Care Med 2014; 40:1399–1408
110. Lopez-Cortes LE, Delgado-Valverde M, Moreno-Mellado E, et al; SIMPLIFY study group: Efficacy and safety of a structured de-escalation from antipseudomonal beta-lactams in bloodstream infections due to Enterobacterales. Lancet Infect Dis 2024; 24:375–385
111. Tabah A, Bassetti M, Kollef MH, et al: Antimicrobial de- escalation in critically ill patients: A position statement from a task force of the European society of intensive care medicine (ESICM) and European society of clinical microbiology and infectious diseases (ESCMID) critically ill patients study group (ESGCIP). Intensive Care Med 2020; 46:245–265
112. NICE organization. Surveillance report 2018 – Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use (2015) NICE guideline NG15. Available at: https://www.nice.org.uk/guidance/ng15/resources/ surveillance-report-2018-antimicrobial-stewardship-systems-and-processes-for-effective-antimicrobial-medicine- use-2015-nice-guideline-ng15-pdf-6119358364357 Accessed July 18, 2025.
113. Dark P, Hossain A, McAuley DF, et al; ADAPT-Sepsis Collaborators: Biomarker-guided antibiotic duration for hospitalized patients with suspected sepsis: The ADAPT-sepsis randomized clinical trial. JAMA 2025; 333:682–693
114. Gershengorn HB, Garland A, Kramer A, et al: Variation of arterial and central venous catheter use in United States in- tensive care units. Anesthesiology 2014; 120:650–664
115. Muller G, Contou D, Ehrmann S, et al: Deferring arterial catheterization in critically ill patients with shock. N Engl J Med 2025; 393:1875–1888
116. Hammond NE, Zampieri FG, Di Tanna GL, et al: Balanced crystalloids versus saline in critically ill adults - A systematic review with meta-analysis. NEJM Evid 2022; 1:EVIDoa2100010
117. Zampieri FG, Cavalcanti AB, Di Tanna GL, et al: Balanced crystalloids versus saline for critically ill patients (BEST-Living): A systematic review and individual patient data meta- analysis. Lancet Respir Med 2024; 12:237–246
118. Diz JC, Luna-Rojas P, Díaz-Vidal P, et al: Effect of treatment with balanced crystalloids versus normal saline on the mortality of critically ill patients with and without traumatic brain injury: A systematic review and meta-analysis. Anesth Analg 2025; 141:152–161
119. Investigators SS, et al: Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 2007; 357:874–884
120. Philips CA, Maiwall R, Sharma MK, et al: Comparison of 5% human albumin and normal saline for fluid resuscitation in sepsis induced hypotension among patients with cirrhosis (FRISC study): A randomized controlled trial. Hepatol Int 2021; 15:983–994
121. Caironi P, Tognoni G, Masson S, et al; ALBIOS Study Investigators: Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med 2014; 370:1412–1421
122. Arabi YM, Belley-Cote E, Carsetti A, et al; European Society of Intensive Care Medicine: European society of intensive care medicine clinical practice guideline on fluid therapy in adult critically ill patients. Part 1: The choice of resuscitation fluids. Intensive Care Med 2024; 50:813–831
123. Rochwerg B, Alhazzani W, Sindi A, et al; Fluids in Sepsis and Septic Shock Group: Fluid resuscitation in sepsis: A systematic review and network meta-analysis. Ann Intern Med 2014; 161:347–355
124. Moeller C, Fleischmann C, Thomas-Rueddel D, et al: How safe is gelatin? A systematic review and meta-analysis of gelatin-containing plasma expanders vs crystalloids and albumin. J Crit Care 2016; 35:75–83
125. Haase N, Perner A, Hennings LI, et al: Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: Systematic review with meta-analysis and trial sequential analysis. BMJ 2013; 346:f839
126. Macdonald SPJ, Keijzers G, Taylor DM, et al; REFRESH trial investigators: Restricted fluid resuscitation in suspected sepsis associated hypotension (REFRESH): A pilot randomized controlled trial. Intensive Care Med 2018; 44:2070–2078
127. Jessen MK, Andersen LW, Thomsen MH, et al: Restrictive fluids versus standard care in adults with sepsis in the emergency department (REFACED): A multicenter, randomized feasibility trial. Acad Emerg Med 2022; 29:1172–1184
128. Meyhoff TS, Hjortrup PB, Wetterslev J, et al; CLASSIC Trial Group: Restriction of intravenous fluid in ICU patients with septic shock. N Engl J Med 2022; 386:2459–2470
129. Bednarczyk JM, Fridfinnson JA, Kumar A, et al: Incorporating dynamic assessment of fluid responsiveness into goal- directed therapy: A systematic review and meta-analysis. Crit Care Med 2017; 45:1538–1545
130. Ehrman RR, Gallien JZ, Smith RK, et al: Resuscitation guided by volume responsiveness does not reduce mortality in sepsis: A meta-analysis. Crit Care Explor 2019; 1:e0015
131. Azadian M, Win S, Abdipour A, et al: Mortality benefit from the passive leg raise maneuver in guiding resuscitation of septic shock patients: A systematic review and meta-analysis of randomized trials. J Intensive Care Med 2022; 37:611–617
132. Basmaji J, Arntfield R, Desai K, et al: The impact of point-of- care ultrasound-guided resuscitation on clinical outcomes in patients with shock: A systematic review and meta-analysis. Crit Care Med 2024; 52:1661–1673
133. Putowski Z, Gołdyn M, Pluta MP, et al: Correlation between mean arterial pressure and capillary refill time in patients with septic shock: A systematic review and meta-analysis. J Intensive Care Med 2023; 38:838–846
134. Hernandez G, Ospina-Tascón GA, Damiani LP, et al; The ANDROMEDA SHOCK Investigators and the Latin America Intensive Care Network (LIVEN): Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: The ANDROMEDA-SHOCK randomized clinical trial. JAMA 2019; 321:654–664
135. Castro R, Kattan E, Ferri G, et al: Effects of capillary refill time-vs. lactate-targeted fluid resuscitation on regional, microcirculatory and hypoxia-related perfusion parameters in septic shock: A randomized controlled trial. Ann Intensive Care 2020; 10:150
136. Kattan E, Bakker J, Estenssoro E, et al: Hemodynamic phenotype-based, capillary refill time-targeted resuscitation in early septic shock: The ANDROMEDA-SHOCK-2 randomized clinical trial study protocol. Rev Bras Ter Intensiva 2022; 34:96–106
137. Levy B: Lactate and shock state: The metabolic view. Curr Opin Crit Care 2006; 12:315–321
138. Pan J, Peng M, Liao C, et al: Relative efficacy and safety of early lactate clearance-guided therapy resuscitation in patients with sepsis: A meta-analysis. Medicine (Baltim) 2019; 98:e14453
139. Gordon AC, Mason AJ, Thirunavukkarasu N, et al; VANISH Investigators: Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: The VANISH randomized clinical trial. JAMA 2016; 316:509–518
140. Hajjar LA, Zambolim C, Belletti A, et al: Vasopressin versus norepinephrine for the management of septic shock in cancer patients: The VANCS II randomized clinical trial. Crit Care Med 2019; 47:1743–1750
141. Khanna A, English SW, Wang XS, et al; ATHOS-3 Investigators: Angiotensin II for the treatment of vasodilatory shock. N Engl J Med 2017; 377:419–430
142. Chawla LS, Busse L, Brasha-Mitchell E, et al: Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study. Crit Care 2014; 18:534
143. Drugs.com. Comparing Levophed vs Vasopressin. Available at: https://www.drugs.com/compare/levophed-vs-vasopres- sin Accessed July 22, 2025
144. Russell JA, Walley KR, Singer J, et al; VASST Investigators: Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008; 358:877–887
145. Chen C, Pang L, Wang Y, et al: Combination era, using combined vasopressors showed benefits in treating septic shock patients: A network meta-analysis of randomized controlled trials. Ann Transl Med 2019; 7:535
146. Myburgh JA, Higgins A, Jovanovska A, et al; CAT Study investigators: A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med 2008; 34:2226–2234
147. Belletti A, Benedetto U, Biondi-Zoccai G, et al: The effect of vasoactive drugs on mortality in patients with severe sepsis and septic shock. A network meta-analysis of randomized trials. J Crit Care 2017; 37:91–98
148. McChesney C, Orozco N, Fiorini K, et al: Impact of short-acting beta-blockers on the outcomes of patients with septic shock: A systematic review and meta-analysis. Crit Care Med 2025; 53:e1125–e1139
149. Kilcommons SJ, Hammal F, Kamaleldin M, et al: Adjunctive midodrine therapy for vasopressor-dependent shock in the ICU: A systematic review and meta-analysis. Crit Care Med 2025; 53:e384–e399
150. Fernando SM, Tran A, Soliman K, et al: Methylene blue in septic shock: A systematic review and meta-analysis. Crit Care Explor 2024; 6:e1110
151. Chaudhuri D, Lazarte J, Shah K, et al. Approaches to converting Spo2/FIO2 ratio to PaO2/FIO2 ratio for assessment of respiratory failure in critically ill patients: A systematic review. Crit Care Med 2026 Jan 6. [online first]
152. Sjoding MW, Dickson RP, Iwashyna TJ, et al: Racial bias in pulse oximetry measurement. N Engl J Med 2020; 383:2477–2478
153. Martin D, Johns C, Sorrell L, et al: Effect of skin tone on the accuracy of the estimation of arterial oxygen saturation by pulse oximetry: A systematic review. Br J Anaesth 2024; 132:945–956
154. Alipanah-Lechner N, Cavalcanti AB, Diaz J, et al: From Berlin to global: The need for syndromic definitions of acute respiratory distress syndrome. Am J Respir Crit Care Med 2024; 209:21–23
155. Klitgaard TL, Schjørring OL, Nielsen FM, et al: Higher versus lower fractions of inspired oxygen or targets of arterial oxygenation for adults admitted to the intensive care unit. Cochrane Database Syst Rev 2023; 9:CD012631
156. Buell KG, Spicer AB, Casey JD, et al: Individualized treatment effects of oxygen targets in mechanically ventilated critically ill adults. JAMA 2024; 331:1195–1204
157. Frat JP, Quenot J-P, Badie J, et al; SOHO-COVID Study Group and the REVA Network: Effect of high-flow nasal cannula oxygen vs standard oxygen therapy on mortality in patients with respiratory failure due to COVID-19: The SOHO-COVID randomized clinical trial. JAMA 2022; 328:1212–1222
158. Perkins GD, Ji C, Connolly BA, et al; RECOVERY-RS Collaborators: Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: The RECOVERY-RS randomized clinical trial. JAMA 2022; 327:546–558
159. Crimi C, Noto A, Madotto F, et al; COVID-HIGH Investigators: High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxemia: A randomized controlled trial. Thorax 2023; 78:354–361
160. Nagata K, Yokoyama T, Tsugitomi R, et al; JaNP-Hi Study Investigators: Continuous positive airway pressure versus high-flow nasal cannula oxygen therapy for acute hypoxemic respiratory failure: A randomized controlled trial. Respirology 2024; 29:36–45
161. Investigators R, et al.: High-flow nasal oxygen vs noninvasive ventilation in patients with acute respiratory failure: The RENOVATE randomized clinical trial. JAMA 2025; 333:875–890
162. Coudroy R, Frat J-P, Ehrmann S, et al; FLORALI-IM study group and the REVA Research Network: High-flow nasal oxygen alone or alternating with non-invasive ventilation in critically ill immunocompromised patients with acute respiratory failure: A randomized controlled trial. Lancet Respir Med 2022; 10:641–649
163. Frat JP, Thille AW, Mercat A, et al; FLORALI Study Group: High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 2015; 372:2185–2196
164. Luo J, Pavlov I, Tavernier E, et al; Awake Prone Positioning Meta-Analysis Group: Awake prone positioning in adults with COVID-19: An individual participant data meta-analysis. JAMA Intern Med 2025; 185:572–581
165. Alhazzani W, Parhar KKS, Weatherald J, et al; COVI- PRONE Trial Investigators and the Saudi Critical Care Trials Group: Effect of awake prone positioning on endo- tracheal intubation in patients with COVID-19 and acute respiratory failure: A randomized clinical trial. JAMA 2022; 327:2104–2113
166. Landry DW, Levin HR, Gallant EM, et al: Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997; 95:1122–1125 354.
167. Gordon AC, Mason AJ, Thirunavukkarasu N, et al; VANISH Investigators: Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: The VANISH randomized clinical trial. JAMA 2016; 316:509–518
168. Brower RG, Matthay MA, Morris A, et al; Acute Respiratory Distress Syndrome Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:1301–1308
169. Hager DN, Krishnan JA, Hayden DL, et al; ARDS Clinical Trials Network: Tidal volume reduction in patients with acute lung injury when plateau pressures are not high. Am J Respir Crit Care Med 2005; 172:1241–1245
170. Checkley W, Brower R, Korpak A, et al; Acute Respiratory Distress Syndrome Network Investigators: Effects of a clinical trial on mechanical ventilation practices in patients with acute lung injury. Am J Respir Crit Care Med 2008; 177:1215–1222
171. Amato MB, Meade MO, Slutsky AS, et al: Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med 2015; 372:747–755
172. de Haro C, Neto AS, Gomà G, et al: Effect of a low versus intermediate tidal volume strategy on pulmonary complications in patients at risk of acute respiratory distress syndrome- a randomized clinical trial. Front Med (Lausanne) 2023; 10:1172434
173. Writing Group for the PI, et al.: Effect of a low vs intermediate tidal volume strategy on ventilator-free days in intensive care unit patients without ARDS: A randomized clinical trial. JAMA 2018; 320:1872–1880
174. Brochard L, Roudot-Thoraval F, Roupie E, et al: Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. The Multicenter Trail Group on Tidal Volume reduction in ARDS. Am J Respir Crit Care Med 1998; 158:1831–1838
175. Brower RG, Shanholtz CB, Fessler HE, et al: Prospective, ran- domized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med 1999; 27:1492–1498
176. Papazian L, Aubron C, Brochard L, et al: Formal guidelines: Management of acute respiratory distress syndrome. Ann Intensive Care 2019; 9:69
177. Laffey JG, Bellani G, Pham T, et al; LUNG SAFE Investigators and the ESICM Trials Group: Potentially modifiable factors contributing to outcome from acute respiratory distress syn- drome: The LUNG SAFE study. Intensive Care Med 2016; 42:1865–1876
178. Villar J, Martín-Rodríguez C, Domínguez-Berrot AM, et al; Spanish Initiative for Epidemiology, Stratification and Therapies for ARDS (SIESTA) Investigators Network: A quantile analysis of plateau and driving pressures: Effects on mortality in patients with acute respiratory distress syn- drome receiving lung-protective ventilation. Crit Care Med 2017; 45:843–850
179. Brower RG, Lanken PN, MacIntyre N, et al; National Heart, Lung, and Blood Institute ARDS Clinical Trials Network: Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004; 351:327–336
180. Meade MO, Cook DJ, Guyatt GH, et al; Lung Open Ventilation Study Investigators: Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: A randomized controlled trial. JAMA 2008; 299:637–645
181. Mercat A, Richard JC, Vielle B, et al: Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: A randomized controlled trial. JAMA 2008; 299:646–655
182. Briel M, Meade M, Mercat A, et al: Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: Systematic review and meta-analysis. JAMA 2010; 303:865–873
183. Cavalcanti AB, Suzumura ÉA, Laranjeira LN, et al: Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs low PEEP on mortality in patients with acute respiratory distress syndrome: A randomized clinical trial. JAMA 2017; 318:1335–1345
184. Munshi L, Del Sorbo L, Adhikari NKJ, et al: Prone position for acute respiratory distress syndrome. A systematic review and meta-analysis. Ann Am Thorac Soc 2017; 14(Suppl 4):S280–S288
185. Guérin C, Reignier J, Richard JC, et al; PROSEVA Study Group: Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013; 368:2159–2168
186. National Heart, Lung, and Blood Institute PETAL Clinical Trials Network; Moss M, Huang DT, Brower RG, et al: Early neuromuscular blockade in the acute respiratory distress syndrome. N Engl J Med 2019; 380:1997–2008
187. Combes A, Hajage D, Capellier G, et al; EOLIA Trial Group, REVA, and ECMONet: Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med 2018; 378:1965–1975
188. Peek GJ, Mugford M, Tiruvoipati R, et al; CESAR trial collaboration: Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): A multicenter randomized controlled trial. Lancet 2009; 374:1351–1363
189. Munshi L, Walkey A, Goligher E, et al: Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: A systematic review and meta-analysis. Lancet Respir Med 2019; 7:163–172
190. Pitre T, Drover K, Chaudhuri D, et al: Corticosteroids in sepsis and septic shock: A systematic review, pairwise, and dose-response meta-analysis. Crit Care Explor 2024; 6:e1000
191. Diaz-Gomez JL, Sharif S, Ablordeppey E, et al: Society of critical care medicine guidelines on adult critical care ultrasonography: Focused update 2024. Crit Care Med 2025; 53:e447–e458
192. Sakkat A, Alquraini M, Aljazeeri J, et al: Temperature control in critically ill patients with fever: A meta-analysis of randomized controlled trials. J Crit Care 2021; 61:89–95
193. Reintam Blaser A, Alhazzani W, Belley-Cote E, et al: Intravenous vitamin C therapy in adult patients with sepsis: A rapid practice guideline. Acta Anaesthesiol Scand 2023; 67:1423–1431
194. Agarwal A, Basmaji J, Fernando SM, et al: Parenteral Vitamin C in patients with severe infection: A systematic review. NEJM Evid 2022; 1:EVIDoa2200105
195. Lamontagne F, Masse M-H, Menard J, et al; LOVIT Investigators and the Canadian Critical Care Trials Group: Intravenous Vitamin C in adults with sepsis in the intensive care unit. N Engl J Med 2022; 386:2387–2398
196. Pan B, Sun P, Pei R, et al: Efficacy of IVIG therapy for patients with sepsis: A systematic review and meta-analysis. J Transl Med 2023; 21:765
197. Kaur M, Soni KD, Trikha A: Does vitamin D improve all-cause mortality in critically ill adults? An updated systematic review and meta-analysis of randomized controlled trials. Indian J Crit Care Med 2022; 26:853–862
198. National Heart L, et al.: Early high-dose Vitamin D(3) for critically ill, Vitamin D-deficient patients. N Engl J Med 2019; 381:2529–2540
199. Liu S, Yao C, Xie J, et al; EXIT-SEP Investigators: Effect of an herbal-based injection on 28-Day mortality in patients with sepsis: The EXIT-SEP randomized clinical trial. JAMA Intern Med 2023; 183:647–655
200. Li C, Wang P, Zhang Li, et al: Efficacy and safety of Xuebijing injection (a Chinese patent) for sepsis: A meta-analysis of randomized controlled trials. J Ethnopharmacol 2018; 224:512–521
201. Wang J, Zhu J, Guo J, et al: Could xuebijing injection reduce the mortality of severe pneumonia patients? A systematic review and meta-analysis. Evid Based Complement Alternat Med 2020; 2020:9605793
202. Chen JJ, Lai P-C, Lee T-H, et al: Blood purification for adult patients with severe infection or sepsis/septic shock: A net- work meta-analysis of randomized controlled trials. Crit Care Med 2023; 51:1777–1789
203. Rimmer E, Houston BL, Kumar A, et al: The efficacy and safety of plasma exchange in patients with sepsis and septic shock: A systematic review and meta-analysis. Crit Care 2014; 18:699
204. American Diabetes Association: 14. Diabetes care in the hospital: Standards of medical care in diabetes—2018. Diabetes Care 2018; 41(Suppl 1):S144–S151
205. Yatabe T, Inoue S, Sakaguchi M, et al: The optimal target for acute glycemic control in critically ill patients: A network meta-analysis. Intensive Care Med 2017; 43:16–28
206. Hirano Y, Miyoshi Y, Kondo Y, et al: Liberal versus restrictive red blood cell transfusion strategy in sepsis or septic shock: A systematic review and meta-analysis of randomized trials. Crit Care 2019; 23:262
207. Bergamin FS, Almeida JP, Landoni G, et al: Liberal versus restrictive transfusion strategy in critically ill oncologic patients: The transfusion requirements in critically ill oncologic patients randomized controlled trial. Crit Care Med 2017; 45:766–773
208. Wang Y, Parpia S, Ge L, et al: Proton-pump inhibitors to pre- vent gastrointestinal bleeding - an updated meta-analysis. NEJM Evid 2024; 3:EVIDoa2400134
209. Cook D, Deane A, Lauzier F, et al; REVISE Investigators: Stress ulcer prophylaxis during Invasive mechanical ventilation. N Engl J Med 2024; 391:9–20
210. Granholm A, Zeng L, Dionne JC, et al; GUIDE Group: Predictors of gastrointestinal bleeding in adult ICU patients: a systematic review and meta-analysis. Intensive Care Med 2019; 45:1347–1359
211. MacLaren R, Dionne JC, Granholm A, et al: Society of Critical Care Medicine and American Society of Health-System Pharmacists Guideline for the Prevention of Stress-Related Gastrointestinal Bleeding in Critically Ill Adults. Crit Care Med 2024; 52:e421–e430
212. STARRT-AKI Investigators; Canadian Critical Care Trials Group; Australian and New Zealand Intensive Care Society Clinical Trials Group; United Kingdom Critical Care Research Group; Canadian Nephrology Trials Network; Irish Critical Care Trials Group; Bagshaw SM, Wald R, Adhikari NKJ; et al: Timing of initiation of renal-replacement therapy in acute kidney injury. N Engl J Med 2020; 383:240–251
213. Zha J, Li C, Cheng G, et al: The efficacy of renal replacement therapy strategies for septic-acute kidney injury: A PRISMAcompliant network meta-analysis. Medicine (Baltimore) 2019; 98:e15257
214. Zhao Y, Chen Y: Effect of renal replacement therapy modalities on renal recovery and mortality for acute kidney injury: A PRISMA-compliant systematic review and meta-analysis. Semin Dial 2020; 33:127–132
215. Reignier J, Boisramé-Helms J, Brisard L, et al; NUTRIREA-2 Trial Investigators; Clinical Research in Intensive Care and Sepsis (CRICS) group: Enteral versus parenteral early nutrition in ventilated adults with shock: A randomized, controlled, multicenter, open-label, parallel-group study (NUTRIREA-2). Lancet 2018; 391:133–143
216. Jaber S, Paugam C, Futier E, et al; BICAR-ICU Study Group: Sodium bicarbonate therapy for patients with severe metabolic acidemia in the intensive care unit (BICAR-ICU): A multicenter, open-label, randomized controlled, phase 3 trial. Lancet 2018; 392:31–40
217. Ostermann M, Alshamsi F, Artigas Raventos A, et al: European society of intensive care medicine clinical practice guideline on fluid therapy in adult critically ill patients: Part 3-fluid removal at de-escalation phase. Intensive Care Med 2025; 51:1749–1763
218. Sharif S, Greer A, Skorupski C, et al: Probiotics in critical ill- ness: A systematic review and meta-analysis of randomized controlled trials. Crit Care Med 2022; 50:1175–1186
219. Johnstone J, Meade M, Lauzier F, et al; Prevention of Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT) Investigators and the Canadian Critical Care Trials Group: Effect of probiotics on incident ventilator- associated pneumonia in critically ill patients: A randomized clinical trial. JAMA 2021; 326:1024–1033
220. Arabi YM, Al-Hameed F, Burns KEA, et al; Saudi Critical Care Trials Group: Adjunctive intermittent pneumatic compression for venous thromboprophylaxis. N Engl J Med 2019; 380:1305–1315
